ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride by Arun, T, Tomassini, V, Sbardella, E, de Ruiter, M, Matthews, L, Leite, M, Cavey, A, Craner, M, Fugger, L, Jenkinson, M, Palace, J

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. by de Ruiter, M, Reneman, L, Boogerd, W, Veltman, D, Caan, M, Douaud, G, Lavini, C, Linn, S, Boven, E, van Dam, F, Schagen, S

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging by De Ruiter, M, Reneman, L, Boogerd, W, Veltman, D, Caan, M, Douaud, G, Lavini, C, Linn, S, Boven, E, Van Dam, F, Schagen, S

Acid-sensing ion channel 1 blockade preserves brain microstructural integrity in patients with multiple sclerosis by de Ruiter, M, Tomassini, V, Arun, T, Jbabdi, S, Matthews, L, Sbardella, E, Gelineau-Morel, R, Leite, M, Jenkinson, M, Johansen-Berg, H, Palace, J

Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride by Arun, T, Tomassini, V, Sbardella, E, De Ruiter, M, Matthews, L, Leite, M, Gelineau-Morel, R, Cavey, A, Vergo, S, Craner, M, Fugger, L, Rovira, A, Jenkinson, M, Palace, J

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. by Arun, T, Tomassini, V, Sbardella, E, de Ruiter, M, Matthews, L, Leite, M, Gelineau-Morel, R, Cavey, A, Vergo, S, Craner, M, Fugger, L, Rovira, A, Jenkinson, M, Palace, J

Standardized outcome measures for pregnancy and childbirth, an ICHOM proposal by Nijagal, M, Wissig, S, Stowell, C, Olson, E, Amer-Wahlin, I, Bonsel, G, Brooks, A, Coleman, M, Karalasingam, S, Duffy, J, Flanagan, T, Gebhardt, S, Greene, M, Groenendaal, F, Jeganathan, R, Kowaliw, T, Lamain-De-Ruiter, M, Main, E, Owens, M, Petersen, R, Reiss, I, Sakala, C, Speciale, A, Thompson, R, Okunade, O, Franx, A